EMA — authorised 28 August 2014
- Application: EMEA/H/C/002347
- Marketing authorisation holder: Acusphere Ltd
- Local brand name: Imagify
- Indication: ultrasound imaging agent indicated for the detection of coronary artery disease (CAD)
- Status: withdrawn
EMA authorised Perfluorobutane on 28 August 2014
Yes. EMA authorised it on 28 August 2014.
Acusphere Ltd holds the EU marketing authorisation.